CD4 and viral infectious disease: Thus, a stable and defined minimal bacterial consortium is able to shape the immune response to a systemic virus infection via enhancing effector cell function of CD4+ T helper cells including cytotoxic T cell subsets and viral clearance at the cost of enhanced disease pathology.